{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:46:43Z","timestamp":1788922003674,"version":"build-2803163510"},"reference-count":42,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,12,17]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To understand the efficacy of aspirin use for preventing ischaemic stroke after central retinal artery occlusion (CRAO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>The retrospective cohort study was conducted using the National Health Insurance Research Database from 1998 to 2013.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A population-based study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 9437 participants with newly diagnosed CRAO were identified. Participants who had a previous stroke and\/or retinal vascular occlusion, were aged &lt;20 years and used aspirin 3 months before the event were excluded. There were 3778 eligible participants matched by propensity score, and they were divided into aspirin (n=434) and aspirin-naive (n=1736) groups after the matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cox proportional hazard models and cumulative survival curves were used to assess ischaemic stroke in the study groups, along with log-rank tests to compare group differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Incidence of ischaemic stroke in the aspirin and aspirin-naive groups 1\u2009year after CRAO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 3778 patients with newly diagnosed CRAO, 151 (4%) had a subsequent ischaemic stroke within 1\u2009year. The risk was especially high during the first week of the CRAO. No difference between the aspirin and aspirin-naive groups was found in risk of ischaemic stroke, haemorrhagic stroke, gastrointestinal bleeding, major bleeding, acute coronary syndrome, retinal vein occlusion, new-onset glaucoma, undergoing panretinal photocoagulation or all-cause mortality. Risk factors for ischaemic stroke within 1\u2009year of CRAO included male gender (p=0.031; HR=1.46) and age (p=0.032; HR=1.14).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Aspirin use after a CRAO showed no benefit on attenuating the risk of ischaemic stroke. The risk of ischaemic stroke was increased after CRAO especially during the first week. Male gender and age were risk factors for ischaemic stroke after CRAO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-025455","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T05:09:08Z","timestamp":1551330548000},"page":"e025455","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan"],"prefix":"10.1136","volume":"9","author":[{"given":"Eugene Yu-Chuan","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan"},{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hsuan","family":"Lin","sequence":"additional","affiliation":[{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan"},{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yeung","sequence":"additional","affiliation":[{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caesar","family":"Luo","sequence":"additional","affiliation":[{"name":"Bay Area Retina Associates, Oakland, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan"},{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chin","family":"Sun","sequence":"additional","affiliation":[{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"},{"name":"Biostatistical Consultation Center, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-Ho","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yang Ming Hospital, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jui","family":"Hung","sequence":"additional","affiliation":[{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Department of Cardiology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Hsing","family":"Chen","sequence":"additional","affiliation":[{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Biostatistical Consultation Center, Chang Gung Memorial Hospital, Keelung, Taiwan"},{"name":"Department of Cardiology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"2025121400402370000_9.2.e025455.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.006"},{"key":"2025121400402370000_9.2.e025455.2","doi-asserted-by":"crossref","first-page":"376.e1","DOI":"10.1016\/j.ajo.2005.03.038","article-title":"Central retinal artery occlusion: visual outcome","volume":"140","author":"Hayreh","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2025121400402370000_9.2.e025455.3","doi-asserted-by":"crossref","unstructured":"Fraser SG , Adams W . Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2009:CD001989.doi:10.1002\/14651858.CD001989.pub2","DOI":"10.1002\/14651858.CD001989.pub2"},{"key":"2025121400402370000_9.2.e025455.4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2011.05.005","article-title":"The incidence of central retinal artery occlusion in Olmsted County, Minnesota","volume":"152","author":"Leavitt","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"2025121400402370000_9.2.e025455.5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ophtha.2014.04.029","article-title":"Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011","volume":"121","author":"Park","year":"2014","journal-title":"Ophthalmology"},{"key":"2025121400402370000_9.2.e025455.6","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.25"},{"key":"2025121400402370000_9.2.e025455.7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2015.05.044","article-title":"Cardiovascular risk factors in central retinal artery occlusion: Results of a prospective and standardized medical examination","volume":"122","author":"Callizo","year":"2015","journal-title":"Ophthalmology"},{"key":"2025121400402370000_9.2.e025455.8","first-page":"30479","article-title":"Stroke risk and risk factors in patients with central retinal artery occlusion","volume":"9394","author":"Lavin","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2025121400402370000_9.2.e025455.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.03.046"},{"key":"2025121400402370000_9.2.e025455.10","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.ophtha.2015.07.018","article-title":"Risk and risk periods for stroke and acute\u00a0myocardial infarction in patients with\u00a0central retinal artery occlusion","volume":"122","author":"Park","year":"2015","journal-title":"Ophthalmology"},{"key":"2025121400402370000_9.2.e025455.11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40123-018-0126-x","article-title":"Ischemic Stroke Risk in Medicare Beneficiaries with Central Retinal Artery Occlusion: A Retrospective Cohort Study","volume":"7","author":"French","year":"2018","journal-title":"Ophthalmol Ther"},{"key":"2025121400402370000_9.2.e025455.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","article-title":"Ocular vascular occlusive disorders: natural history of visual outcome","volume":"41","author":"Hayreh","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"2025121400402370000_9.2.e025455.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"2025121400402370000_9.2.e025455.14","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2013.1197"},{"key":"2025121400402370000_9.2.e025455.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000230"},{"key":"2025121400402370000_9.2.e025455.16","doi-asserted-by":"crossref","first-page":"10:10","DOI":"10.1007\/s12170-015-0480-3","article-title":"Primary Prevention of Atherosclerotic Cardiovascular Disease in Women","volume":"10","author":"McKibben","year":"2016","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"2025121400402370000_9.2.e025455.17","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut333"},{"key":"2025121400402370000_9.2.e025455.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.09.029"},{"key":"2025121400402370000_9.2.e025455.19","doi-asserted-by":"publisher","DOI":"10.1136\/emj.17.5.324"},{"key":"2025121400402370000_9.2.e025455.20","unstructured":"Bowling B . Retinal Vascular Disease :In. Kanski\u2019s Clinical Ophthalmology: A Systematic Approach. 8th ed. China: Elsevier, 2016:555."},{"key":"2025121400402370000_9.2.e025455.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550020017009"},{"key":"2025121400402370000_9.2.e025455.22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","article-title":"Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database","volume":"175","author":"Hsing","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025121400402370000_9.2.e025455.23","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11975"},{"key":"2025121400402370000_9.2.e025455.24","first-page":"620","article-title":"Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study","volume":"56","author":"Hsu","year":"2017","journal-title":"Rheumatology"},{"key":"2025121400402370000_9.2.e025455.25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2016.08.121","article-title":"Effect of dialysis dependence and duration on post-coronary artery bypass grafting outcomes in patients with chronic kidney disease: A nationwide cohort study in Asia","volume":"223","author":"Chen","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025121400402370000_9.2.e025455.26","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2025121400402370000_9.2.e025455.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.01.033"},{"key":"2025121400402370000_9.2.e025455.28","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198807000-00012"},{"key":"2025121400402370000_9.2.e025455.29","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ophtha.2018.03.054","article-title":"Management of Acute Retinal Ischemia: Follow the Guidelines!","volume":"125","author":"Biousse","year":"2018","journal-title":"Ophthalmology"},{"key":"2025121400402370000_9.2.e025455.30","unstructured":"Aspirin: Drug information. UpToDate\u00ae Topic 8907 Version 195.0. https:\/\/www.uptodate.com\/ (Retrieved 17 Apr 2017)."},{"key":"2025121400402370000_9.2.e025455.31","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.10.1206"},{"key":"2025121400402370000_9.2.e025455.32","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2302"},{"key":"2025121400402370000_9.2.e025455.33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2025121400402370000_9.2.e025455.34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"2016","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2025121400402370000_9.2.e025455.35","doi-asserted-by":"publisher","DOI":"10.3310\/hta21410"},{"key":"2025121400402370000_9.2.e025455.36","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000120741.34866.1D"},{"key":"2025121400402370000_9.2.e025455.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.11.053"},{"key":"2025121400402370000_9.2.e025455.38","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2087"},{"key":"2025121400402370000_9.2.e025455.39","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20140076"},{"key":"2025121400402370000_9.2.e025455.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177663","article-title":"Retinal artery occlusion and associated recurrent vascular risk with underlying etiologies","volume":"12","author":"Hong","year":"2017","journal-title":"PLoS One"},{"key":"2025121400402370000_9.2.e025455.41","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200206000-00002"},{"key":"2025121400402370000_9.2.e025455.42","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.12.1602"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-025455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:40:33Z","timestamp":1765701633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-025455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,27]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjopen-2018-025455"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-025455","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}